46411-5 |
Somatotropin^45M post dose arginine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
46411-5 |
|
|
|
|
Observation |
|
|
|
0 |
GH 45M p Arg SerPl-mCnc |
|
|
|
N |
|
45M p Arg; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.19 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
46412-3 |
Somatotropin^105M post dose arginine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --105 minutes post dose arginine |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
46412-3 |
|
|
|
|
Both |
|
|
|
0 |
GH 105M p Arg SerPl-mCnc |
|
|
|
N |
|
105M p Arg; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.58 |
2.19 |
|
|
|
|
|
|
|
ng/mL |
|
|
Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. |
0 |
46413-1 |
Calcitonin^7M post 0.5 ug/kg pentagastrin IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcitonin [Mass/volume] in Serum or Plasma --7 minutes post 0.5 ug/kg pentagastrin IV |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
46413-1 |
|
|
|
|
Both |
|
|
|
0 |
Calcit 7M p 0.5 ug/kg Pg IV SerPl-mCnc |
|
|
|
N |
|
7M p 0.5 ug/kg Pg IV; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker |
2.34 |
2.19 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
46414-9 |
Lutropin^15M post dose gonadotropin releasing hormone |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --15 minutes post dose gonadotropin releasing hormone |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;IU/L |
|
|
|
|
|
|
CHAL |
|
46414-9 |
|
|
|
|
Observation |
|
|
|
0 |
LH 15M p GnRH SerPl-aCnc |
|
|
|
N |
|
15M p GnRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.68 |
2.19 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
46415-6 |
Lutropin^45M post dose gonadotropin releasing hormone |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --45 minutes post dose gonadotropin releasing hormone |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;IU/L |
|
|
|
|
|
|
CHAL |
|
46415-6 |
|
|
|
|
Observation |
|
|
|
0 |
LH 45M p GnRH SerPl-aCnc |
|
|
|
N |
|
45M p GnRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.68 |
2.19 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
46416-4 |
Cortisol^8H post 8 mg dexamethasone PO overnight high dose |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 8 mg dexamethasone PO overnight high dose |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
46416-4 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 8h p 8 mg Dex SerPl-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; 8h p 8 mg Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hi dose; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.4 |
2.19 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
46417-2 |
Coagulation tissue factor induced |
Time |
BldC |
Pt |
Qn |
Coag |
|
ACTIVE |
Prothrombin time (PT) in Capillary blood by Coagulation assay |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
46417-2 |
|
Coag |
|
|
Both |
|
|
|
0 |
PT BldC |
|
|
|
N |
|
Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Finger stick; Hematology; Heme; Point in time; Pro time; Prothrombin time; Protime; PT; QNT; Quan; Quant; Quantitative; Random; Tilt tube |
2.73 |
2.19 |
|
|
|
|
|
|
|
s |
|
|
|
0 |
46418-0 |
Coagulation tissue factor induced.INR |
RelTime |
BldC |
Pt |
Qn |
Coag |
|
ACTIVE |
INR in Capillary blood by Coagulation assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
46418-0 |
|
Coag |
|
|
Observation |
|
|
|
0 |
INR BldC |
|
|
|
N |
|
Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Finger stick; Hematology; Heme; Internat norm ratio; International normal ratio; International normalization ratio; International normalized ratio; Point in time; Pro time; Prothrombin time; Prothrombin time INR; Protime; Protime INR; PT; PT INR; QNT; Quan; Quant; Quantitative; Random; RlTm; Tilt tube |
2.73 |
2.19 |
|
|
|
|
|
|
|
|
|
|
|
0 |
46419-8 |
Erythrocytes |
Naric |
Urine sed |
Pt |
Qn |
Automated count |
|
ACTIVE |
Erythrocytes [#/area] in Urine sediment by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
46419-8 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
RBC #/area UrnS Auto |
|
|
|
N |
|
#/area; Auto; Automated detection; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
2.19 |
|
|
|
|
|
|
|
/[HPF] |
|
|
Specimen changed from Urine to Urine sediment since results generated by analyzers assume a spun urine. |
0 |
4642-5 |
Hemopexin |
MCnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Hemopexin [Mass/volume] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
4642-5 |
|
|
|
|
|
|
|
|
0 |
Deprecated Hemopexin Ser-mCnc |
|
|
|
|
|
Haemopexin; HEMATOLOGY/CELL COUNTS; Hx; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
46420-6 |
Leukocyte clumps |
Naric |
Urine sed |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Leukocyte clumps [#/area] in Urine sediment by Microscopy high power field |
|
MIN |
DefinitionDescription |
|
|
/HPF |
|
|
|
|
|
|
UA |
|
46420-6 |
|
Microscopy.light.HPF |
|
|
Observation |
|
|
|
0 |
WBC clumps #/area UrnS HPF |
|
|
|
N |
|
#/area; Kidney; Leuc; Leuk; Leukocytes; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBC clumps; WBCs; White blood cell; White blood cells |
2.73 |
2.19 |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
46421-4 |
Mucus |
Naric |
Urine sed |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Mucus [#/area] in Urine sediment by Microscopy high power field |
|
MIN |
DefinitionDescription |
|
|
/HPF |
|
|
|
|
|
|
UA |
|
46421-4 |
|
Microscopy.light.HPF |
|
|
Observation |
|
|
|
0 |
Mucous Threads #/area UrnS HPF |
|
|
|
N |
|
#/area; Kidney; LM; Micro; Micros; Microscopic; Mucous; Mucous Threads; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
2.19 |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
46422-2 |
Trichomonas vaginalis |
Naric |
Urine sed |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Trichomonas vaginalis [#/area] in Urine sediment by Microscopy high power field |
|
MIN |
DefinitionDescription |
|
|
/HPF |
|
|
|
|
|
|
UA |
|
46422-2 |
|
Microscopy.light.HPF |
|
|
Observation |
|
|
|
0 |
T vaginalis #/area UrnS HPF |
|
|
|
N |
|
#/area; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
2.19 |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
46423-0 |
Hemoglobin distribution width |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Hemoglobin distribution width [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
HEM/BC |
|
46423-0 |
|
|
|
|
Both |
|
|
|
0 |
HDW Bld-mCnc |
|
|
|
N |
|
Blood; Haemoglobin; Hb; HDW; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.19 |
|
|
|
|
|
|
|
g/dL |
|
|
|
0 |
46424-8 |
Hemolysis interference index |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Hemolysis interference index of Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
46424-8 |
|
|
|
|
Observation |
|
|
|
0 |
Hemolysis interf index SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Hem; Hemolysis interf index; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR |
2.73 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Release 2.70: COMPONENT: Added the word "interference" to the Component to clarify the meaning; |
0 |
46425-5 |
Lipemic interference index |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lipemic interference index of Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
46425-5 |
|
|
|
|
Observation |
|
|
|
0 |
Lipemic interf index SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Lipemic interf index; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR |
2.73 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Release 2.70: COMPONENT: Added the word "interference" to the Component to clarify the meaning; |
0 |
46426-3 |
Icteric interference index |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Icteric interference index of Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
46426-3 |
|
|
|
|
Observation |
|
|
|
0 |
Icteric interf index SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Icteric interf index; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR |
2.73 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Release 2.70: COMPONENT: Added the word "interference" to the Component to clarify the meaning; |
0 |
46427-1 |
Beta fructofuranosidase |
CCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Beta fructofuranosidase [Enzymatic activity/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
U/g |
|
|
|
|
|
|
CHEM |
|
46427-1 |
|
|
|
|
Both |
|
|
|
0 |
B-Fructofuranosidase Tiss-cCnt |
|
|
|
N |
|
B; Beta fructosidase; B-Fructofuranosidase; Catalytic Content; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Saccharase; Tissue; Tissue, unspecified |
2.42 |
2.19 |
|
|
|
|
|
|
|
U/g |
|
|
|
0 |
46428-9 |
Xylose^15M post 25 g xylose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Mass/volume] in Serum or Plasma --15 minutes post 25 g xylose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL;ug/dL |
|
|
|
|
|
|
CHAL |
|
46428-9 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 15M p 25 g Xyl PO SerPl-mCnc |
|
|
|
N |
|
15M p 25 g Xyl PO; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; Mass concentration; p 25 g Xyl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylose absorption test |
2.4 |
2.19 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
46429-7 |
Alpha 1 antitrypsin |
MCnt |
Stool |
24H |
Qn |
|
|
ACTIVE |
Alpha 1 antitrypsin [Mass/mass] in 24 hour Stool |
|
MIN |
DefinitionDescription |
|
|
mg/g |
|
|
|
|
|
|
CHEM |
|
46429-7 |
|
|
|
|
Both |
|
|
|
0 |
A1AT 24h Stl-mCnt |
|
|
|
N |
|
1 day; 24 hours; 24HR; A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Hepatology; i; Liver; Lung; Mass Content; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Stl; Stool = Fecal |
2.73 |
2.19 |
|
|
|
|
|
|
|
mg/g |
|
|
|
0 |
4643-3 |
Hemosiderin |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Hemosiderin [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
4643-3 |
|
|
|
|
Both |
|
|
|
0 |
Hemosiderin Ser-mCnc |
|
|
|
Y |
|
HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.34 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
46430-5 |
Alpha 1 antitrypsin |
MCnt |
Stool |
48H |
Qn |
|
|
ACTIVE |
Alpha 1 antitrypsin [Mass/mass] in 48 hour Stool |
|
MIN |
DefinitionDescription |
|
|
mg/g |
|
|
|
|
|
|
CHEM |
|
46430-5 |
|
|
|
|
Both |
|
|
|
0 |
A1AT 48h Stl-mCnt |
|
|
|
N |
|
2 days; 2D; 48 hours; 48HR; A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Hepatology; i; Liver; Lung; Mass Content; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Stl; Stool = Fecal |
2.42 |
2.19 |
|
|
|
|
|
|
|
mg/g |
|
|
|
0 |
46431-3 |
Alpha 1 antitrypsin |
MCnt |
Stool |
72H |
Qn |
|
|
ACTIVE |
Alpha 1 antitrypsin [Mass/mass] in 72 hour Stool |
|
MIN |
DefinitionDescription |
|
|
mg/g |
|
|
|
|
|
|
CHEM |
|
46431-3 |
|
|
|
|
Both |
|
|
|
0 |
A1AT 72h Stl-mCnt |
|
|
|
N |
|
3 days; 72 hours; 72HR; A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Hepatology; i; Liver; Lung; Mass Content; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Stl; Stool = Fecal |
2.42 |
2.19 |
|
|
|
|
|
|
|
mg/g |
|
|
|
0 |
46432-1 |
Hydrogen/Expired gas^post 50 g lactose PO |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 50 g lactose PO |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHAL |
|
46432-1 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 p 50 g Lact PO |
|
|
|
N |
|
After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p 50 g Lact PO; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.42 |
2.19 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
46433-9 |
Hydrogen/Expired gas^post 10 g lactulose PO |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 10 g lactulose PO |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHAL |
|
46433-9 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 p 10 g Lactulose PO |
|
|
|
N |
|
After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Lac PO; p 10 g Lactulose PO; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.42 |
2.19 |
|
|
|
|
|
|
|
% |
|
|
|
0 |